Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

Hicham Lahlou, Virginie Sanguin-Gendreau, Dongmei Zuo, Robert Cardiff, Gordon W. McLean, Margaret C. Frame, William J. Muller

Research output: Contribution to journalArticle

143 Scopus citations

Abstract

Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.

Original languageEnglish (US)
Pages (from-to)20302-20307
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number51
DOIs
StatePublished - Dec 18 2007

Keywords

  • Breast cancer
  • Cre recombinase
  • Transgenic

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression'. Together they form a unique fingerprint.

  • Cite this